909 results on '"Feuer, Eric J"'
Search Results
102. Impact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975–2000
103. Predicting US- and state-level cancer counts for the current calendar year: Part II: evaluation of spatiotemporal projection methods for incidence
104. Predicting US- and state-level cancer counts for the current calendar year: Part I: evaluation of temporal projection methods for mortality
105. Projections of the Cost of Cancer Care in the United States: 2010–2020
106. Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study
107. The Effect of Advances in Lung-Cancer Treatment on Population Mortality
108. The Joinpoint-Jump and Joinpoint-Comparability Ratio Model for Trend Analysis with Applications to Coding Changes in Health Statistics
109. Disparities of National Lung Cancer Screening Guidelines in the US Population
110. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence declinein the United States
111. Using Patient Preferences to Determine Noninferiority Margins in Trials
112. A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies
113. Analyzing discrete competing risks data with partially overlapping or independent data sources and nonstandard sampling schemes, with application to cancer registries
114. Estimating Lifetime and Age-Conditional Probabilities of Developing Cancer
115. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms
116. Breast cancer survivors in the United States: Geographic Variability and Time Trends, 2005-2015
117. CANSURV: A Windows program for population-based cancer survival analysis
118. Updated Methodology for Projecting U.S.- and State-Level Cancer Counts for the Current Calendar Year: Part I: Spatio-temporal Modeling for Cancer Incidence.
119. Productivity Costs of Cancer Mortality in the United States: 2000–2020
120. Estimates and Projections of Value of Life Lost From Cancer Deaths in the United States
121. Improved Survival Time: What Can Survival Cure Models Tell Us About Population-Based Survival Improvements in Late-Stage Colorectal, Ovarian, and Testicular Cancer?
122. Reconstructing Psa Testing Patterns Between Black and White Men in the Us From Medicare Claims and the National Health Interview Survey
123. Evaluating cluster alarms: a space-time scan statistic and brain cancer in Los Alamos, New Mexico
124. Estimates of long-term survival for newly diagnosed cancer patients: A projection approach
125. Racial/ethnic patterns in lifetime and age-conditional risk estimates for selected cancers
126. A new method of estimating United States and state-level cancer incidence counts for the current calendar year
127. An Ecologic Study of Prostate-specific Antigen Screening and Prostate Cancer Mortality in Nine Geographic Areas of the United States
128. Cancer statistics, 2005
129. Number of helper T cells and phytohemagglutinin stimulation correlate in cancer patients
130. Re: Trends in Use of Adjuvant Multi-Agent Chemotherapy and Tamoxifen for Breast Cancer in the United States: 1975–1999
131. A new method of predicting US and state-level cancer mortality counts for the current calendar year
132. Cancer statistics, 2004
133. Trends in Use of Adjuvant Multi-Agent Chemotherapy and Tamoxifen for Breast Cancer in the United States: 1975–1999
134. Impact of Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends
135. The prevalence of patients with colorectal carcinoma under care in the U.S
136. Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends
137. Changing Area Socioeconomic Patterns in U.S. Cancer Mortality, 1950–1998: Part I—All Cancers Among Men
138. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data
139. Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates
140. Impact of Screening on Incidence and Mortality of Prostate Cancer in the United States
141. Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force.
142. Role of Transurethral Resection of the Prostate in Population-based Prostate Cancer Incidence Rates
143. Cancer Surveillance Series: Interpreting Trends in Prostate Cancer—Part I: Evidence of the Effects of Screening in Recent Prostate Cancer Incidence, Mortality, and Survival Rates
144. Cancer Surveillance Series: Interpreting Trends in Prostate Cancer—Part III:Quantifying the Link Between Population Prostate-Specific Antigen Testing and Recent Declines in Prostate Cancer Mortality
145. Cancer Surveillance Series: Interpreting Trends in Prostate Cancer—Part II: Cause of Death Misclassification and the Recent Rise and Fall in Prostate Cancer Mortality
146. Does Size Matter? Association Between Number of Patients Treated and Patient Outcome in Metastatic Testicular Cancer
147. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics
148. Early Estimates of Cancer Incidence for 2015: Expanding to Include Estimates for White and Black Races
149. Small Area Estimation of Cancer Risk Factors and Screening Behaviors in US Counties by Combining Two Large National Health Surveys
150. Improved Monte Carlo methods for estimating confidence intervals for eleven commonly used health disparity measures
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.